Lonza signs manufacturing agreement with Oasmia Pharmaceutical
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Subscribe To Our Newsletter & Stay Updated